DE2404931A1 - Psychotonikum - Google Patents
PsychotonikumInfo
- Publication number
- DE2404931A1 DE2404931A1 DE2404931A DE2404931A DE2404931A1 DE 2404931 A1 DE2404931 A1 DE 2404931A1 DE 2404931 A DE2404931 A DE 2404931A DE 2404931 A DE2404931 A DE 2404931A DE 2404931 A1 DE2404931 A1 DE 2404931A1
- Authority
- DE
- Germany
- Prior art keywords
- phosphoric acid
- pyridoxine
- serine
- serine phosphoric
- hydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- -1 phosphoric acid pyridoxine hydrate Chemical compound 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 3
- IPGWPDHPOQYBMR-UHFFFAOYSA-N 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol;phosphoric acid Chemical compound OP(O)(O)=O.CC1=NC=C(CO)C(CO)=C1O IPGWPDHPOQYBMR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- ORRZGUBHBVWWOP-UHFFFAOYSA-N 4-ethyl-4-methylpiperidine-2,6-dione Chemical compound CCC1(C)CC(=O)NC(=O)C1 ORRZGUBHBVWWOP-UHFFFAOYSA-N 0.000 description 1
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 102100035472 DNA polymerase iota Human genes 0.000 description 1
- 101001094672 Homo sapiens DNA polymerase iota Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960000750 bemegride Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22138/73A IT1054123B (it) | 1973-03-26 | 1973-03-26 | Fosfoserinato di piridossina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2404931A1 true DE2404931A1 (de) | 1974-10-03 |
Family
ID=11192049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2404931A Pending DE2404931A1 (de) | 1973-03-26 | 1974-02-01 | Psychotonikum |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5024431A (xx) |
| BE (1) | BE810912A (xx) |
| CH (1) | CH586202A5 (xx) |
| DE (1) | DE2404931A1 (xx) |
| ES (1) | ES417230A1 (xx) |
| FR (1) | FR2222999B1 (xx) |
| GB (1) | GB1411364A (xx) |
| IT (1) | IT1054123B (xx) |
| NL (1) | NL7402986A (xx) |
| ZA (1) | ZA741530B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2461725A1 (en) * | 1979-07-16 | 1981-02-06 | Sarget Sa Labo | Mono and bis di:isopropylamine serine-phosphate(s) - are peripheral vasodilators and antiparkinson agents |
| US4675474A (en) * | 1985-09-04 | 1987-06-23 | Harvey Hubbell Incorporated | Reinforced electrical cable and method of forming the cable |
| JP3533605B2 (ja) * | 2001-12-06 | 2004-05-31 | すこやか食品株式会社 | 血圧降下、心臓強化、動脈硬化防止、血管保護、抗疲労、運動機能向上、エネルギー代謝効率向上、抗酸化などの諸効果を有する栄養補助食品。 |
-
1973
- 1973-03-26 IT IT22138/73A patent/IT1054123B/it active
- 1973-07-24 ES ES417230A patent/ES417230A1/es not_active Expired
-
1974
- 1974-02-01 DE DE2404931A patent/DE2404931A1/de active Pending
- 1974-02-04 FR FR7403634A patent/FR2222999B1/fr not_active Expired
- 1974-02-12 BE BE140814A patent/BE810912A/xx unknown
- 1974-02-14 CH CH203774A patent/CH586202A5/xx not_active IP Right Cessation
- 1974-03-05 NL NL7402986A patent/NL7402986A/xx unknown
- 1974-03-08 ZA ZA00741530A patent/ZA741530B/xx unknown
- 1974-03-19 GB GB1220874A patent/GB1411364A/en not_active Expired
- 1974-03-25 JP JP49033344A patent/JPS5024431A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2222999B1 (xx) | 1978-01-06 |
| FR2222999A1 (xx) | 1974-10-25 |
| BE810912A (fr) | 1974-05-29 |
| CH586202A5 (xx) | 1977-03-31 |
| IT1054123B (it) | 1981-11-10 |
| ZA741530B (en) | 1975-02-26 |
| GB1411364A (en) | 1975-10-22 |
| ES417230A1 (es) | 1976-02-16 |
| NL7402986A (xx) | 1974-09-30 |
| JPS5024431A (xx) | 1975-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2524059A1 (de) | Kontrastmittel fuer roentgenaufnahmen | |
| DE2359334A1 (de) | Verfahren zur herstellung einer hochkonzentrierten waessrigen loesung einer dopaverbindung | |
| IL27058A (en) | Novel salts of 5-(p-(2-pyridylsulphamyl)-phenylazo)-salicylic acid and method of producing same | |
| DE2404931A1 (de) | Psychotonikum | |
| EP0257572B1 (de) | Neue Thyroninderivate | |
| DE3231103C2 (xx) | ||
| DE2124904C3 (de) | Hydroxy- und Alkoxyacetamido-trijodbenzoesäuren, deren Salze mit physiologisch verträglichen Basen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Röntgenkontrastmittel | |
| DE829166C (de) | Verfahren zur Herstellung von N-(p-Arsenosobenzyl)-glycinamid und dessen Salzen | |
| DE412171C (de) | Verfahren zur Darstellung von in Wasser loeslichen organischen Arsen- und Antimonverbindungen | |
| DE917005C (de) | Verfahren zur Herstellung quecksilberhaltiger Propylharnstoffe | |
| DE818047C (de) | Verfahren zur Herstellung von konzentrierten neutralen Loesungen des Theophyllins | |
| DE944731C (de) | Verfahren zur Herstellung von p-Aminobenzolsulfonamid-Abkoemmlingen | |
| DE833192C (de) | Verfahren zur Herstellung eines Calciumphosphat-Komplexsalzes der p-Aminosalicylsaeure | |
| DE255030C (xx) | ||
| DE1793218C3 (de) | Wasserlösliche 21-Hemisulfatalkalimetallverbindungen von 6 a-Fluor- 11 ß, 21-dihydroxy-16 a-methyl- 3,20-dioxo-l,4pregnadienen, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE342048C (de) | Verfahren zur Herstellung hydrierter 2-Phenylchinolin-4-carbonsaeure, deren Homologeund Salzen dieser Saeuren | |
| DE1493919C (de) | Verfahren zur Herstellung von Sulfo derivaten des Hydrochinons | |
| DE267411C (xx) | ||
| DE962545C (de) | Roentgenkontrastmittel | |
| DE541147C (de) | Verfahren zur Herstellung wasserloeslicher Salze der Phenylchinolincarbonsaeure und ihrer Derivate | |
| DE736661C (de) | Verfahren zur Herstellung von p-Acylaminobenzolsulfonsaeureamidverbindungen | |
| DE2433723A1 (de) | Neue sulfonamidderivate | |
| AT309669B (de) | Röntgenkontrastmittel | |
| DE1695158A1 (de) | Verfahren zur Herstellung von Antibiotika | |
| DE890345C (de) | Verfahren zur Herstellung hydrierter Formylpteroinsaeuren |